Michael S. Balzer

Keep Calm & Carry On
Inhibiting RAS 👑

#Kidneywk #Nephjc

👉 www.nephjc.com/news/stopacei
👉 www.nephjc.com/news/aceing-...

Well deserved, Rafael! Congrats!

👏Huge congratulations to my fantastic mentor @ksusztak.bsky.social for receiving the 2025 ASN Homer Smith award.

👏Fantastic to see @cetinsz.bsky.social from our team presenting insights into #single-cell transcriptomic patterns distinguishing recovery from non-recovery after #AKI. Exciting 🧪 at #KidneyWk Houston, TX! #MedSky #NephSky

❓Do we finally have a nodular sclerosis mouse model for DKD? 🔥Tour-de-force #kidneywk talk by @linkermannlab.bsky.social suggests so. 🧪 #NephSky #MedSky

Cell Decoder: decoding cell identity with multi-scale explainable deep learning. #SingleCellOmics #CellCharacterization #GenomeBiology 🧪🧬 🖥️
genomebiology.biomedcentral.com/articles/10....

spatial Omics in R/Bioconductor 18-20 May 2026 To foster international participation, this course will be held online

🚀 Curious about #SpatialOmics? Want to master spatial omics data analysis using #Rstats and @bioconductor.bsky.social ?

🔥 Registrations are now OPEN for the 3rd edition of our hands-on course with @stemang.bsky.social !

📅 Save the dates: 18–20 May 2026
www.physalia-courses.org/courses-work...

Thx, Rebecca!

Thanks, Tilo! 👍

💯👍

Thanks, Lennard! 🙏

The ERC awards €761m to the next generation of scientists in Europe The European Research Council (ERC) has selected 478 early-career researchers across Europe to receive this year’s Starting Grants. With a total funding of €761 million, these grants support excellent...

🚀Excited to announce that I’ve been awarded an @erc.europa.eu StG to advance research how kidneys heal themselves — a paradigm shift for understanding & treating #kidneydisease 🫘🩺🧬🧪
👉ERC press release: t.ly/CBxwB
👉Charité press release: t.ly/SR_Wn
#ERCStG #HorizonEU #KidneyResearch #NephSky #MedSky

Integration of spatial protein imaging and transcriptomics in the human kidney tracks the regenerative potential of proximal tubules The interplay in expression of the stem cell markers THY1 and PROM1 in kidney proximal tubules marks the timeline of disease.

📑 Need something to read this weekend? If so, you're in luck!

"Integration of spatial protein imaging and transcriptomics in the human kidney tracks the regenerative potential of proximal tubules" fueled by #KPMP investigators is hot off the press today @science.org

www.science.org/doi/10.1126/...

🔥 Huge congrats to @ksusztak.bsky.social & team on a landmark @natgenet.nature.com paper!
🚶‍♂️🐁🐀Cross-species 🫘kidney pathway dysregulation via #singlecell functional profiling of individual samples — opening new therapeutic avenues.
🔗 www.nature.com/articles/s41...
🧪 #NephSky #MedSky

🔥Paper alert @nature.com. Fantastic 🧪resource for the renal 🫘 community! #NephSky #MedSky

Congrats @puellesv.bsky.social lab and team!

Randomized, Double-Blind, Placebo-Controlled Phase 2a Study Assessing the Efficacy and Safety of Felzartamab for IgA Nephropathy

doi.org/10.1016/j.kint.2025.05.028

#OpenAccess #IgAN #felzartamab #IgANephropathy

Simon Davies kicking off day 2 of the 1st International Meeting on
Cellular and Molecular Peritonial Dialysis Research in Kiel.

KidneyCure 2025 Grant Recipients

👏Congrats to the KidneyCure 2025 Grant Recipients! 🫘🧪
@asnpublications.bsky.social #NephSky #MedSky

In the latest video in our partnership with @glaucomflecken.bsky.social, the BALANCE trial comparing 7 days of antibiotic treatment with 14 days of treatment in patients with bloodstream infection is explained. Access the article for free: nej.md/DrG19

ISPD Fellowship results - 1st call 2025 - International Society for Peritoneal Dialysis The Fellowship Program is one of the ISPD’s key programs to strengthen global PD expertise through hands-on learning and knowledge exchange. For the first round of 2025, we received 17…

The Fellowship Program is one of the ISPD’s key instruments to strengthen global PD expertise through hands-on learning and knowledge exchange.

Learn more about the results of our first call for applications in 2025 and the new application modality for teams Doctor-Nurse.

buff.ly/7XjuPCM

Go Nina! Love the fancy ambience.

A graph of the least-squares mean ratio of the change from baseline in the urinary albumin-to-creatinine ratio in the full analysis population.

In the CONFIDENCE trial in persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either drug alone. Full trial results: nej.md/4jEVbbk

#ERA25 #MedSky #Nephrology

Go Braunschweig! 🫘

ASN Lifetime & Midcareer Awardees 2025

🎉🎈Congrats to all ASN 2025 🏆Lifetime & Midcareer awardees!

Well-deserved, @ksusztak.bsky.social @rkramann.bsky.social @genetickidneydoc.bsky.social, you are on 🔥!!!
#NephSky, #MedSky, #ERA25

In the May 2025 #ASNKidneyNews Policy Update, explore recent new and existing policy actions from ASN Advocacy that benefit physicians, patients, and researchers. bit.ly/KN1705-16

Figure Full season (32-week-ahead) forecasts of influenza hospitalisations in the USA

The effect of disappearing data from US public health

#OpenAccess viewpoint in @thelancet.com

www.thelancet.com/journals/lan...

#MedSky #EpiSky

Program & registration: http://www.pdmeeting.skip-sh.de

📣Attention #NephSky #MedSky!
Inaugural #PeritonealDialysis 🧪research meeting incoming:

"1st International Meeting on Cellular & Molecular #PD Research"
📆July 4-5, 2025 @The Nucleus, 🛳️Kiel, Germany
🔗Program & registration: www.pdmeeting.skip-sh.de
👫@ispd.org @dgfn.bsky.social ERA/EDTA

⏳ Two Weeks Left! Submit your research abstract or case report for #KidneyWk 2025 by Wednesday, May 21, at 2:00 p.m. EDT.

Take the stage at the world’s premier nephrology meeting and share your work with 12,000+ kidney professionals.

Submit now: asn.kdny.info/SwgN50VMhU6

Fluoroscopic repositioning of Tenckhoff catheter

doi.org/10.1016/j.kint.2024.09.027

#KINephrologyImage #NephSky #MedSky #peritonealdialysis